EZZ Life Science Holdings Limited (ASX:EZZ)
Australia
· Delayed Price · Currency is AUD 0.740
-0.015 (-1.99%)
Apr 29, 2026, 10:29 AM AEST
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 35.54 million as of April 29, 2026. Its market cap has decreased by -48.40% in one year.
Market Cap
35.54M
Enterprise Value
20.98M
Revenue
61.40M
Ranking
n/a
PE Ratio
12.31
Stock Price
0.74
Market Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has decreased from 48.72M to 35.54M, a decrease of -27.06%. That is a compound annual growth rate of -5.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 35.54M | -46.43% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroScientific Biopharmaceuticals | 38.25M |
| Avecho Biotechnology | 40.41M |
| Imugene | 41.06M |
| Proteomics International Laboratories | 43.77M |
| Algorae Pharmaceuticals | 24.28M |
| Noxopharm | 23.35M |
| Entropy Neurodynamics | 56.30M |
| Prescient Therapeutics | 57.31M |